Evidence map›Paper›PMID 29141563›Full record

ReviewAnti-cancer agents in medicinal chemistry2018

Ganoderma lucidum Polysaccharides as An Anti-cancer Agent.

Didem Sohretoglu, Shile Huang

2 registry-linked trialsOpen access · greenAbstract readReview
In one paragraph

Review in Anti-cancer agents in medicinal chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
11.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06598033 phase2 / phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer

TypeinterventionalSponsorFudan UniversityRan2024 to 2027Enrolled50ConditionsPancreatic CancerArmsVC plus herbal medicine
NCT06601283 phase2 / phase3recruitingnot on this mapstarted 2024, after this paper: background citation

Vitamin C Plus Cordyceps to Chemotherapy Related Anemia in Pancreatic Cancer

TypeinterventionalSponsorFudan UniversityRan2024 to 2027Enrolled50ConditionsPancreatic CancerArmsVitmain C plus herbal medicine
3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 225 citations in OpenAlex.

  1. International journal of molecular medicine · 2026
    Article
  2. Article
  3. Pharmaceutics · 2026
    Article
  4. Article
  5. Development of HybridFoods (Basel, Switzerland) · 2025
    Article
  6. Review
  7. Article
  8. Article
  9. Effect ofFood science & nutrition · 2025
    Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Effects of JUNCAOAnimal biotechnology · 2024
    Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Didem SohretogluDepartment of Pharmacognosy, Faculty of Pharmacy, Hacettepe University, TR 06100, Ankara, Turkey.
Shile HuangDepartment of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center, 1501 Kings Highway, Shreveport, LA 71130-3932, United States.
Hacettepe University · TRLouisiana State University Health Sciences Center Shreveport · US

Funding

mTOR Signaling in Tumor Cell MotilityR01CA115414 · NCI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI HUANG, SHILE · 2006 to 2009
$811k
NCI NIH HHS R01 CA115414
6 · The paper itself

Abstract

The mushroom Ganoderma lucidum (G. lucidum) has been used for centuries in Asian countries to treat various diseases and to promote health and longevity. Clinical studies have shown beneficial effects of G. lucidum as an alternative adjuvant therapy in cancer patients without obvious toxicity. G. lucidum polysaccharides (GLP) is the main bioactive component in the water soluble extracts of this mushroom. Evidence from in vitro and in vivo studies has demonstrated that GLP possesses potential anticancer activity through immunomodulatory, anti-proliferative, pro-apoptotic, anti-metastatic and anti-angiogenic effects. Here, we briefly summarize these anticancer effects of GLP and the underlying mechanisms.

Indexed as

Angiogenesis InhibitorsAntineoplastic Agents, PhytogenicCell ProliferationHumansNeoplasmsPolysaccharidesReishiAngiogenesis InhibitorsAntineoplastic Agents, PhytogenicPolysaccharidesanti-angiogenicanti-canceranti-metastaticanti-proliferativeGanoderma lucidum polysaccharidesimmunomodulatorypro-apoptotic.Reishi

Identifiers

PMID29141563
PMCPMC6624854
OpenAlexW2769263042

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.